throbber
1/6/2019
`
`Drug Approvals and Databases > Inactive Ingredient Search for Approved Drug Products: Frequently Asked Questions
`
`Inactive Ingredient Search for Approved
`Drug Products: Frequently Asked
`Questions
`
`Most recent changes to the database (/Drugs/InformationOnDrugs/ucm567080.htm) (updated 7/14/2017)
`Search the Inactive Ingredient Database (http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm)
`
`About the Inactive Ingredient Database
`1. What is an inactive ingredient?
`2. What is an active ingredient?
`3. What is the purpose of the Inactive Ingredient Database?
`4. How do you use the Inactive Ingredient Database?
`5. What is maximum potency?
`6. Can an inactive ingredient ever be considered an active ingredient?
`7. Does the Inactive Ingredient Database include contaminants found in approved drug products?
`8. What is a CAS Number?
`9. What is a UNII?
`10. How often do you update the Inactive Ingredient Database?
`11. How can I get a copy of the Inactive Ingredient Database?
`
` 1. What is an inactive ingredient?
`
`According to 21 CFR 210.3(b)(8), an inactive ingredient is any component of a drug product other than the active
`ingredient. Only inactive ingredients in the final dosage forms of drug products are in this database.
`
`back to top
`
`2. What is an active ingredient?
`
`According to 21 CFR 210.3(b)(7), an active ingredient is any component of a drug product intended to furnish
`pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease,
`or to affect the structure or any function of the body of humans or other animals. Active ingredients include those
`components of the product that may undergo chemical change during the manufacture of the drug product and be
`present in the drug product in a modified form intended to furnish the specified activity or effect.
`
`back to top
`
`https://www.fda.gov/drugs/informationondrugs/ucm080123.htm
`
`1/4
`
`1
`
`AMN1045
`Amneal v. Almirall, LLC
`IPR2019-00207
`
`

`

`1/6/2019
`
`Drug Approvals and Databases > Inactive Ingredient Search for Approved Drug Products: Frequently Asked Questions
`
`3. What is the purpose of the Inactive Ingredient Database?
`
`The Inactive Ingredient Database provides information on inactive ingredients present in FDA-approved drug
`products. This information can be used by industry as an aid in developing drug products. For new drug
`development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route
`of administration, the inactive ingredient is not considered new and may require a less extensive review the next
`time it is included in a new drug product. For example, if a particular inactive ingredient has been approved in a
`certain dosage form at a certain potency, a sponsor could consider it safe for use in a similar manner for a similar
`type of product.
`
`back to top
`
`4. How do you use the Inactive Ingredient Database?
`
`You can search the Inactive Ingredient Database by entering any portion of the name of an inactive ingredient. You
`must enter at least three characters. Search results are displayed alphabetically, sorted first by ingredient, then by
`the route of administration and dosage form. Routes of administration and dosage forms are derived from current
`approved labeling.
`
`Field Descriptions (/Drugs/InformationOnDrugs/ucm075230.htm)
`
`back to top
`
`5. What is maximum potency?
`
`Maximum potency is the amount of the excipient used in the approved product that is the basis for the IID listing.
`The IID lists the highest amount of the excipient per unit dose in each dosage form in which it is used. The amounts
`shown for maximum potency do not reflect the maximum daily intake (MDI) of the excipient unless the maximum
`daily dose of the product that is the basis for the listing is only a single unit. For topical products and other products
`where excipients are expressed as a percentage of the product formula, maximum potency is the highest formula
`percentage. Maximum potency of an excipient is a dynamic value that changes when FDA approves products with
`new, higher levels of the excipient. After approval, these new maximum potencies will appear in the next publication
`of the IID.
`
`6. Can an inactive ingredient ever be considered an active ingredient?
`
`The Inactive Ingredient Database contains inactive ingredients specifically intended as such by the manufacturer.
`Inactive ingredients can also be considered active ingredients under certain circumstances, according to the
`definition of an active ingredient given in 21 CFR 210.3(b)(7). Alcohol is a good example of an ingredient that
`may be considered either active or inactive depending on the product formulation.
`
`Reactants in radiopharmaceutical kits, or inactive ingredients that physically or chemically combine with active
`ingredients to facilitate drug transport are considered inactive ingredients.
`
`back to top
`
`7. Does the Inactive Ingredient Database include contaminants found in approved drug products?
`
`No. The Inactive Ingredients Database does not include contaminants found in approved drug products.
`
`back to top
`
`8. What is a CAS Number?
`
`https://www.fda.gov/drugs/informationondrugs/ucm080123.htm
`
`2/4
`
`2
`
`

`

`1/6/2019
`
`Drug Approvals and Databases > Inactive Ingredient Search for Approved Drug Products: Frequently Asked Questions
`
`The acronym "CAS" stands for "Chemical Abstracts Service," a division of the American Chemical Society that
`provides comprehensive electronic chemical information services. CAS assigns unique CAS Registry Numbers to
`chemical substances. Many inactive ingredients have CAS Registry Numbers, which are useful in searching other
`databases for chemical information. The CAS Registry Number itself has no chemical significance.
`
`back to top
`
`9. What is a UNII?
`
`The acronym “UNII” stands for “Unique Ingredient Identifier”. The UNII is a part of the joint United States
`Pharmacopeia (USP)/FDA Substance Registration System (SRS), which has been designed to support health
`information technology initiatives by providing unique identifiers for substances in drugs, biologics, foods, and
`devices based on molecular structure and/or descriptive information. The SRS is used to generate permanent,
`unique, unambiguous identifiers for substances in regulated products, such as ingredients in drug products. The
`UNII is being displayed in association with inactive ingredients to facilitate Structured Product Labeling
`(http://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/default.htm) (SPL), which
`requires that a UNII be used for all ingredients, including inactive ingredients.
`
`Not all inactive ingredients will have a UNII. In order to receive a UNII, an ingredient must be a ‘substance’, which is
`defined as “Any physical material that has a discrete existence, irrespective of origin.” Products will not be assigned
`a UNII. For example, “purified water” and “sterile water for injection” are considered products within the context of
`the SRS because something is done to the substance “water” in order to make it more useful. Proprietary
`ingredients, such as “OPADRY II 85F10919 BLUE”, are considered products and will not be assigned a UNII. Such
`products are denoted by "N/A".
`
`More information about the UNII and the SRS is available at Substance Registration System - Unique
`Ingredient Identifier (UNII) (http://www.fda.gov/ForIndustry/DataStandards/SubstanceRegistrationSystem-
`UniqueIngredientIdentifierUNII/default.htm). All chemically-related questions about the UNII or the SRS that are
`not answered on the FDA website should be directed fda-srs@fda.hhs.gov (mailto:fda-srs@fda.hhs.gov).
`
`back to top
`
`10. How often do you update the Inactive Ingredient Database?
`
`We update the database quarterly, by the tenth working day of April, July, October, and January.
`
`back to top
`
`11. How can I get a copy of the Inactive Ingredient Database?
`
`You can download the contents of the Inactive Ingredient Database. The Inactive Ingredient Database Download
`(/Drugs/InformationOnDrugs/ucm113978.htm) are provided as delimited text and Excel files.
`
`Text files since 2009 are provided in order to track previous changes.
`
`Data field descriptions (/Drugs/InformationOnDrugs/ucm075230.htm)
`
`
`back to top
`
`Inactive Ingredient Database Help and Information files
`
`https://www.fda.gov/drugs/informationondrugs/ucm080123.htm
`
`3/4
`
`3
`
`

`

`1/6/2019
`
`Drug Approvals and Databases > Inactive Ingredient Search for Approved Drug Products: Frequently Asked Questions
`
`Inactive Ingredients Database Help, Instruction, and Download files
`
`Inactive Ingredient Field Descriptions (/Drugs/InformationOnDrugs/ucm075230.htm)
`Inactive Ingredient Database Download (/Drugs/InformationOnDrugs/ucm113978.htm)
`
`Resources for You
`
`Structured Product Labeling Resources (/ForIndustry/DataStandards/StructuredProductLabeling/default.htm)
`Substance Registration System - Unique Ingredient Identifier (UNII)
`(/ForIndustry/DataStandards/SubstanceRegistrationSystem-UniqueIngredientIdentifierUNII/default.htm)
`CDER FOIA Electronic Reading Room
`(/Drugs/GuidanceComplianceRegulatoryInformation/CDERFOIAElectronicReadingRoom/default.htm)
`Inactive Ingredients Database Download (/Drugs/InformationOnDrugs/ucm113978.htm)
`
`More in Drug Approvals and Databases
`(/Drugs/InformationOnDrugs/default.htm)
`
`Approved Drugs (/Drugs/InformationOnDrugs/ApprovedDrugs/default.htm)
`
`
`
`https://www.fda.gov/drugs/informationondrugs/ucm080123.htm
`
`4/4
`
`4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket